← FDA DRUG APPROVALS

FDA ANDA · ANDA207350

MAGNESIUM SULFATE IN WATER

magnesium sulfate

Sponsor: HQ SPCLT PHARMA

APPLICATION

ANDA207350

TYPE

ANDA

ORIGINAL APPROVAL

2017-12-06

LATEST ACTION

2017-12-06

ROUTE

INTRAVENOUS, INJECTION

DOSAGE FORM

INJECTABLE

MARKETING STATUS

Prescription

Products

MAGNESIUM SULFATE IN PLASTIC CONTAINERPrescription

MAGNESIUM SULFATE 40GM/1000ML (40MG/ML) · INJECTABLE · INJECTION

MAGNESIUM SULFATE IN PLASTIC CONTAINERPrescription

MAGNESIUM SULFATE 4GM/50ML (80MG/ML) · INJECTABLE · INJECTION

MAGNESIUM SULFATE IN PLASTIC CONTAINERPrescription

MAGNESIUM SULFATE 2GM/50ML (40MG/ML) · INJECTABLE · INJECTION

MAGNESIUM SULFATE IN PLASTIC CONTAINERPrescription

MAGNESIUM SULFATE 20GM/500ML (40MG/ML) · INJECTABLE · INJECTION

MAGNESIUM SULFATE IN PLASTIC CONTAINERPrescription

MAGNESIUM SULFATE 4GM/100ML (40MG/ML) · INJECTABLE · INJECTION

Approval history

2017-12-06UNKNOWN · Original · standardAP

VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →